{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:40:39Z","timestamp":1772264439268,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10072-024-07746-8","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T08:02:41Z","timestamp":1725436961000},"page":"351-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The coincidence of multiple sclerosis and primary vasculitis; from the bench of pathology to the bedside of treatment: a systematic review of case reports"],"prefix":"10.1007","volume":"46","author":[{"given":"Melika Arab","family":"Bafrani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Asadigandomani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naghmeh Abbasi","family":"Kasbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hora","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-9983","authenticated-orcid":false,"given":"Sharareh","family":"Eskandarieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"issue":"1","key":"7746_CR1","first-page":"1","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi N, Razavi S, Nikzad E (2017) Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J (Yakhteh) 19(1):1","journal-title":"Cell J (Yakhteh)"},{"issue":"14","key":"7746_CR2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van Der Mei I, Wallin M (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS. Multiple Scler J 26(14):1816\u20131821","journal-title":"Multiple Scler J"},{"issue":"3","key":"7746_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1053\/j.sult.2020.02.004","volume":"41","author":"VL Jewells","year":"2020","unstructured":"Jewells VL, Latchaw RE (2020) CNS Vasculitis-An overview of this multiple sclerosis Mimic: clinical and MRI implications. Semin Ultrasound CT MR 41(3):296\u2013308","journal-title":"Semin Ultrasound CT MR"},{"key":"7746_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2193","volume":"9","author":"L Guillevin","year":"2007","unstructured":"Guillevin L, D\u00f6rner T (2007) Vasculitis: mechanisms involved and clinical manifestations. Arthritis Res Therapy 9:1\u20139","journal-title":"Arthritis Res Therapy"},{"issue":"2","key":"7746_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ (2003) Medium-and large-vessel vasculitis. N Engl J Med 349(2):160\u2013169","journal-title":"N Engl J Med"},{"key":"7746_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fneur.2019.00591","volume":"10","author":"D Strunk","year":"2019","unstructured":"Strunk D, Schmidt-Pogoda A, Beuker C, Milles LS, Korsukewitz C, Meuth SG, Minnerup J (2019) Biomarkers in vasculitides of the nervous system. Front Neurol 10:591","journal-title":"Front Neurol"},{"key":"7746_CR7","unstructured":"DeVrieze BW, Hurley JA, Goodpasture Syndrome [Updated 2022 Sep 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459291\/"},{"key":"7746_CR8","doi-asserted-by":"publisher","first-page":"1759720X2211499","DOI":"10.1177\/1759720X221149963","volume":"15","author":"LC Burg","year":"2023","unstructured":"Burg LC, Karakostas P, Behning C, Brossart P, Kermani TA, Sch\u00e4fer VS (2023) Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica\u2013a prospective cohort study. Therapeutic Adv Musculoskelet Disease 15:1759720X221149963","journal-title":"Therapeutic Adv Musculoskelet Disease"},{"issue":"4","key":"7746_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/1573397115666190227194014","volume":"15","author":"A Ciofalo","year":"2019","unstructured":"Ciofalo A, Gulotta G, Iannella G, Pasquariello B, Manno A, Angeletti D, Pace A, Greco A, Altissimi G, de Vincentiis M, Magliulo G (2019) Giant cell arteritis (GCA): Pathogenesis, clinical aspects and treatment approaches. Curr Rheumatol Rev 15(4):259\u2013268","journal-title":"Curr Rheumatol Rev"},{"issue":"12","key":"7746_CR10","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1016\/j.radcr.2021.09.030","volume":"16","author":"K Dedushi","year":"2021","unstructured":"Dedushi K, Hyseni F, Musa J, Rahman M, Saliaj K, Vokshi V, Shatri J, Siddik AB, Ahsan E, Ikram S, Abdullahu B (2021) MRI diagnosis of Takayasu arteritis in a young woman. Radiol Case Rep 16(12):3915\u20133919","journal-title":"Radiol Case Rep"},{"key":"7746_CR11","volume-title":"ABC of arterial and venous disease","year":"2009","unstructured":"Donnelly R, London NJ (eds) (2009) ABC of arterial and venous disease. Wiley. Apr 8"},{"key":"7746_CR12","doi-asserted-by":"publisher","first-page":"814075","DOI":"10.3389\/fmed.2021.814075","volume":"8","author":"F Regola","year":"2022","unstructured":"Regola F, Uzzo M, Toniati P, Trezzi B, Sinico RA, Franceschini F (2022) Novel therapies in Takayasu arteritis. Front Med 8:814075","journal-title":"Front Med"},{"issue":"3","key":"7746_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/1744666X.2017.1232165","volume":"13","author":"S Agarwal","year":"2017","unstructured":"Agarwal S, Agrawal DK (2017) Kawasaki disease: etiopathogenesis and novel treatment strategies. Expert Rev Clin Immunol 13(3):247\u2013258","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"7746_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/01.meg.0000108362.41221.57","volume":"16","author":"HL Janssen","year":"2004","unstructured":"Janssen HL, van Zonneveld M, van Nunen AB, Niesters HG, Schalm SW, de Man RA (2004) Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome. Eur J Gastroenterol Hepatol 16(8):801\u2013807","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"7746_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1148\/radiographics.21.1.g01ja16151","volume":"21","author":"AW Stanson","year":"2001","unstructured":"Stanson AW, Friese JL, Johnson CM, McKusick MA, Breen JF, Sabater EA, Andrews JC (2001) Polyarteritis nodosa: spectrum of angiographic findings. Radiographics 21(1):151\u2013159","journal-title":"Radiographics"},{"key":"7746_CR16","doi-asserted-by":"crossref","unstructured":"Russe-Russe JR, Pellegrini JR Jr, Alvarez-Betancourt A, Munshi RF, Anand P, Betancourt AA, Munshi RF (2021) Fulminant anti-neutrophil cytoplasmic antibody-associated vasculitis after 10 years of hydralazine use. Cureus. ;13(10)","DOI":"10.7759\/cureus.18974"},{"key":"7746_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.abd.2020.04.004","volume":"95","author":"TC Morita","year":"2020","unstructured":"Morita TC, Criado PR, Criado RF, Tr\u00e9s GF, Sotto MN (2020) Update on vasculitis: overview and relevant dermatological aspects for the clinical and histopathological diagnosis-part II. An Bras Dermatol 95:493\u2013507","journal-title":"An Bras Dermatol"},{"issue":"4","key":"7746_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.autrev.2014.12.004","volume":"14","author":"A Greco","year":"2015","unstructured":"Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, Altissimi G, De Vincentiis M (2015) Churg\u2013Strauss syndrome. Autoimmun rev 14(4):341\u2013348","journal-title":"Autoimmun rev"},{"issue":"2","key":"7746_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0394632015617063","volume":"29","author":"A Greco","year":"2016","unstructured":"Greco A, Marinelli C, Fusconi M, Macri GF, Gallo A, De Virgilio A, Zambetti G, de Vincentiis M (2016) Clinic manifestations in granulomatosis with polyangiitis. Int J ImmunoPathol Pharmacol 29(2):151\u2013159","journal-title":"Int J ImmunoPathol Pharmacol"},{"issue":"1","key":"7746_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/rheumatology\/keaa416","volume":"60","author":"CA Durel","year":"2021","unstructured":"Durel CA, Sinico RA, Teixeira V, Jayne D, Belenfant X, Marchand-Adam S, Pugnet G, Gaultier J, Le Gallou T, Titeca-Beauport D, Agard C (2021) Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases. Rheumatology 60(1):359\u2013365","journal-title":"Rheumatology"},{"key":"7746_CR21","doi-asserted-by":"crossref","unstructured":"Lababidi MH, Odigwe C, Okolo C, Elhassan A, Iroegbu N Microscopic polyangiitis causing diffuse alveolar hemorrhage and rapidly progressive glomerulonephritis. InBaylor University Medical Center Proceedings 2015 Oct 1 (Vol. 28, No. 4, pp. 469\u2013471). Taylor & Francis","DOI":"10.1080\/08998280.2015.11929311"},{"key":"7746_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-11-12","volume":"11","author":"GD Walters","year":"2010","unstructured":"Walters GD, Willis NS, Craig JC (2010) Interventions for renal vasculitis in adults. A systematic review. BMC Nephrol 11:1\u201323","journal-title":"BMC Nephrol"},{"issue":"5","key":"7746_CR23","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/bjd.13472","volume":"172","author":"EF Johnson","year":"2015","unstructured":"Johnson EF, Lehman JS, Wetter DA, Lohse CM, Tollefson MM (2015) Henoch-Sch\u00f6nlein purpura and systemic disease in children: retrospective study of clinical findings, histopathology and direct immunofluorescence in 34 paediatric patients. Br J Dermatol 172(5):1358\u20131363","journal-title":"Br J Dermatol"},{"key":"7746_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/PHMT.S379862","volume":"14","author":"M Sestan","year":"2023","unstructured":"Sestan M, Jelusic M (2023) Diagnostic and management strategies of IgA Vasculitis Nephritis\/Henoch-Sch\u00f6nlein Purpura Nephritis in Pediatric patients: current perspectives. Pediatr Health Med Ther 14:89\u201398","journal-title":"Pediatr Health Med Ther"},{"issue":"976","key":"7746_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/pgmj.2006.046078","volume":"83","author":"GS Braun","year":"2007","unstructured":"Braun GS, Horster S, Wagner KS, Ihrler S, Schmid H (2007) Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects. Postgrad Med J 83(976):87\u201394","journal-title":"Postgrad Med J"},{"key":"7746_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11739-021-02688-x","volume":"16","author":"P Fraticelli","year":"2021","unstructured":"Fraticelli P, Benfaremo D, Gabrielli A (2021) Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med 16:831\u2013841","journal-title":"Intern Emerg Med"},{"issue":"7","key":"7746_CR27","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2215\/CJN.01380217","volume":"12","author":"SP McAdoo","year":"2017","unstructured":"McAdoo SP, Pusey CD (2017) Anti-glomerular basement membrane disease. Clin J Am Soc Nephrology: CJASN 12(7):1162","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"key":"7746_CR28","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71 Published 2021 Mar 29","journal-title":"BMJ"},{"key":"7746_CR29","doi-asserted-by":"publisher","first-page":"103928","DOI":"10.1016\/j.msard.2022.103928","volume":"63","author":"SG Ezabadi","year":"2022","unstructured":"Ezabadi SG, Sahraian MA, Maroufi H, Shahrbaf MA, Eskandarieh S (2022) Global assessment of characteristics of multiple sclerosis registries; a systematic review. Mult Scler Relat Disord 63:103928. https:\/\/doi.org\/10.1016\/j.msard.2022.103928","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"7746_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1590\/1516-3180.2017.0277100917","volume":"136","author":"ESN Volpato","year":"2018","unstructured":"Volpato ESN, Betini M, Puga ME et al (2018) Strategies to optimize MEDLINE and EMBASE search strategies for anesthesiology systematic reviews. An experimental study [published correction appears in Sao Paulo Med J. 2018 Jan-Feb;136(1):98]. Sao Paulo Med J 136(2):103\u2013108 Published 2018 Jan 15. https:\/\/doi.org\/10.1590\/1516-3180.2017.0277100917","journal-title":"Sao Paulo Med J"},{"issue":"3","key":"7746_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000444019","volume":"46","author":"S Eskandarieh","year":"2016","unstructured":"Eskandarieh S, Heydarpour P, Minagar A, Pourmand S, Sahraian MA (2016) Multiple sclerosis epidemiology in East Asia, South East Asia and South Asia: a systematic review. Neuroepidemiology 46(3):209\u2013221. https:\/\/doi.org\/10.1159\/000444019","journal-title":"Neuroepidemiology"},{"issue":"3","key":"7746_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.18502\/cjn.v20i3.7693","volume":"20","author":"H Maroufi","year":"2021","unstructured":"Maroufi H, Mortazavi SH, Sahraian MA, Eskandarieh S (2021) Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: a systematic review. Curr J Neurol 20(3):166\u2013184. https:\/\/doi.org\/10.18502\/cjn.v20i3.7693PMID: 38011462; PMCID: PMC8984778","journal-title":"Curr J Neurol"},{"key":"7746_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Reviews 5:1\u20130","journal-title":"Syst Reviews"},{"key":"7746_CR34","doi-asserted-by":"crossref","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ evidence-based medicine. Feb 2","DOI":"10.1136\/bmjebm-2017-110853"},{"issue":"3","key":"7746_CR35","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/s10165-011-0529-1","volume":"22","author":"AP Diamantopoulos","year":"2012","unstructured":"Diamantopoulos AP, Hetland H, Hansen AE, Myklebust G (2012) Severe deterioration of newly diagnosed Takayasu arteritis in a patient re-treated with interferon beta-1\u03b1 for concomitant longstanding multiple sclerosis. Mod Rheumatol 22(3):474\u2013478","journal-title":"Mod Rheumatol"},{"key":"7746_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jon19922136","volume":"2","author":"A Brashear","year":"1992","unstructured":"Brashear A, Pascuzzi RM (1992) Takayasu\u2019s arteritis and multiple sclerosis. J Neuroimag 2:36\u201338","journal-title":"J Neuroimag"},{"issue":"4","key":"7746_CR37","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1111\/jdv.16107","volume":"34","author":"KM Matsuda","year":"2020","unstructured":"Matsuda KM, Koguchi A, Toyama T, Sakuishi K, Kobayashi M, Miura S, Miyazaki M, Suga H, Asano Y, Toda T, Sato S (2020) Concurrence of polyarteritis nodosa and multiple sclerosis. J Eur Acad Dermatology Venereology: JEADV 34(4):e188\u2013e191","journal-title":"J Eur Acad Dermatology Venereology: JEADV"},{"issue":"4","key":"7746_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1017\/S0317167100019855","volume":"1","author":"H Waisburg","year":"1974","unstructured":"Waisburg H, Meloff KL, Buncic R (1974) Polyarteritis nodosa complicated by a multiple sclerosis like syndrome. Can J Neurol Sci 1(4):250\u2013252","journal-title":"Can J Neurol Sci"},{"key":"7746_CR39","first-page":"bcr0620114300","volume":"2011","author":"P Sarkar","year":"2011","unstructured":"Sarkar P, Ibitoye RT, Promnitz DA (2011) Churg\u2013Strauss syndrome in a patient previously diagnosed with multiple sclerosis. Case Rep 2011:bcr0620114300","journal-title":"Case Rep"},{"issue":"1","key":"7746_CR40","first-page":"31","volume":"89","author":"V Aldasoro-C\u00e1ceres","year":"2014","unstructured":"Aldasoro-C\u00e1ceres V, Aldasoro-C\u00e1ceres I, P\u00e9rez-Moreiras JV, Muri\u00e9-Fern\u00e1ndez M, Ib\u00e1\u00f1ez-Bosch R (2014) C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: treatment with rituximab. Arch De La Sociedad Espa\u00f1ola De Oftalmolog\u00eda (English Edition) 89(1):31\u201334","journal-title":"Arch De La Sociedad Espa\u00f1ola De Oftalmolog\u00eda (English Edition)"},{"key":"7746_CR41","doi-asserted-by":"crossref","unstructured":"Sauer EM, Schliep S, Manger B, Lee DH, Linker RA (2018) Microscopic polyangiitis after alemtuzumab treatment in relapsing-remitting MS. Neurology-Neuroimmunology Neuroinflammation. ;5(5)","DOI":"10.1212\/NXI.0000000000000488"},{"key":"7746_CR42","unstructured":"Garten L, Edwards K, Lezcano C, Spiro J, Siuta J, Belcher S Case report: leukocytoclastic vasculitis in an MS patient following alemtuzumab treatment (P5. 403)"},{"key":"7746_CR43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.msard.2019.02.020","volume":"30","author":"J Dur\u00e3es","year":"2019","unstructured":"Dur\u00e3es J, Gon\u00e7alo M, Sousa L, Mac\u00e1rio MC (2019) Hypocomplementemic urticarial vasculitis and multiple sclerosis: a rare association or an atypical presentation? Multiple Scler Relat Disorders 30:244\u2013246","journal-title":"Multiple Scler Relat Disorders"},{"issue":"5","key":"7746_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/09546630801961067","volume":"19","author":"D Cicek","year":"2008","unstructured":"Cicek D, Kandi B, Oguz S, Cobanoglu B, Bulut S, Saral Y (2008) An urticarial vasculitis case induced by glatiramer acetate. J Dermatological Treat 19(5):305\u2013307","journal-title":"J Dermatological Treat"},{"issue":"5","key":"7746_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/WNF.0b013e3181a2b5fd","volume":"32","author":"J Szilasiov\u00e1","year":"2009","unstructured":"Szilasiov\u00e1 J, Gdovinov\u00e1 Z, Jautov\u00e1 J, Baloghov\u00e1 J, Ficov\u00e1 M, Bohu\u0161 P (2009) Cutaneous vasculitis associated with interferon \u03b2-1b treatment for multiple sclerosis. Clin Neuropharmacol 32(5):301\u2013303","journal-title":"Clin Neuropharmacol"},{"issue":"12","key":"7746_CR46","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1177\/1352458519895449","volume":"26","author":"A Horisberger","year":"2020","unstructured":"Horisberger A, Pantazou V, Cuendet G, Ribi C, Dunet V, Th\u00e9audin M (2020) ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis. Multiple Scler J 26(12):1599\u20131602","journal-title":"Multiple Scler J"},{"issue":"12","key":"7746_CR47","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1177\/13524585211022719","volume":"27","author":"K Sch\u00f6nfelder","year":"2021","unstructured":"Sch\u00f6nfelder K, Schuh H, Pfister F, Kr\u00e4mer J, Eisenberger U, Skuljec J, Hackert J, Ruck T, Pfeuffer S, Fleischer M, G\u00e4ckler A (2021) Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment. Multiple Scler J 27(12):1960\u20131964","journal-title":"Multiple Scler J"},{"issue":"2","key":"7746_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1600-0404.1998.tb01733.x","volume":"98","author":"RD Henderson","year":"1998","unstructured":"Henderson RD, Saltissi D, Pender MP (1998) Case report goodpasture\u2019s syndrome associated with multiple sclerosis. Acta Neurol Scand 98(2):134\u2013135","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"7746_CR49","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1017\/cjn.2018.325","volume":"45","author":"E Lapointe","year":"2018","unstructured":"Lapointe E, Moghaddam B, Barclay K, Traboulsee AL, Neufeld P (2018) Goodpasture\u2019s syndrome following alemtuzumab therapy in multiple sclerosis. Can J Neurol Sci 45(6):712\u2013714","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"7746_CR50","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.msard.2012.07.002","volume":"2","author":"D Meyer","year":"2013","unstructured":"Meyer D, Coles A, Oyuela P, Purvis A, Margolin DH (2013) Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing\u2013remitting multiple sclerosis. Multiple Scler Relat Disorders 2(1):60\u201363","journal-title":"Multiple Scler Relat Disorders"},{"issue":"7","key":"7746_CR51","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/NEJMc0800484","volume":"359","author":"MR Clatworthy","year":"2008","unstructured":"Clatworthy MR, Wallin EF, Jayne DR (2008) Anti\u2013glomerular basement membrane disease after alemtuzumab. N Engl J Med 359(7):768\u2013769","journal-title":"N Engl J Med"},{"key":"7746_CR52","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00415-005-0934-5","volume":"253","author":"AJ Coles","year":"2006","unstructured":"Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, Seaman S, Miller DH, Hale G, Waldmann H, Compston DA (2006) The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol 253:98\u2013108","journal-title":"J Neurol"},{"issue":"1","key":"7746_CR53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/qjmed\/90.1.61","volume":"90","author":"NJ Scolding","year":"1997","unstructured":"Scolding NJ, Jayne DR, Zajicek JP, Meyer PA, Wraight EP, Lockwood CM (1997) Cerebral vasculitis\u2014recognition, diagnosis and management. QJM: Int J Med 90(1):61\u201373","journal-title":"QJM: Int J Med"},{"key":"7746_CR54","unstructured":"Kieseier BC, Hartung HP Current disease-modifying therapies in multiple sclerosis. InSeminars in neurology 2003 (Vol. 23, No. 02, pp. 133\u2013146). Copyright\u00a9 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.:+ 1 (212) 584\u20134662"},{"key":"7746_CR55","first-page":"677","volume":"23","author":"N Mistry","year":"2009","unstructured":"Mistry N, Shapero J, Crawford RI (2009) A review of adverse cutaneous drug reactions resulting from the use of interferon and Ribavirin. Can J Gastroenterol Hepatol 23:677\u2013683","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"10","key":"7746_CR56","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jocn.2006.07.011","volume":"14","author":"T Gono","year":"2007","unstructured":"Gono T, Matsuda M, Shimojima Y, Kaneko K, Murata H, Ikeda SI (2007) Lupus erythematosus profundus (lupus panniculitis) induced by interferon-\u03b2 in a multiple sclerosis patient. J Clin Neurosci 14(10):997\u20131000","journal-title":"J Clin Neurosci"},{"issue":"10","key":"7746_CR57","doi-asserted-by":"publisher","first-page":"a032029","DOI":"10.1101\/cshperspect.a032029","volume":"8","author":"S Katsavos","year":"2018","unstructured":"Katsavos S, Coles A (2018) Alemtuzumab as Treatment for multiple sclerosis. Cold Spring Harb Perspect Med 8(10):a032029","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"7746_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/1756285614563522","volume":"8","author":"E Havrdova","year":"2015","unstructured":"Havrdova E, Horakova D, Kovarova I (2015) Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use. Ther Adv Neurol Disord 8(1):31\u201345","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"7746_CR59","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s13311-017-0573-4","volume":"14","author":"G Giovannoni","year":"2017","unstructured":"Giovannoni G (2017) Cladribine to treat relapsing forms of multiple sclerosis. Neurotherapeutics 14(4):874\u2013887","journal-title":"Neurotherapeutics"},{"issue":"3","key":"7746_CR60","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","volume":"15","author":"M Filippi","year":"2016","unstructured":"Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintor\u00e8 M, Frederiksen JL, Gasperini C (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 15(3):292\u2013303","journal-title":"Lancet Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07746-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07746-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07746-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T11:07:57Z","timestamp":1735902477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07746-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7746"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07746-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"15 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors has a conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of competing interest"}},{"value":"Data can be shared upon the request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and data sharing"}},{"value":"The study protocol was approved by the institutional review boards (IRB) at ethics committee of Tehran University of medical sciences (IR.TUMS.NI.REC.1401.086).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"None","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}}]}}